08045479032

Change Language

Parshva Agency
GST : 27AAAPR8475Q1ZQ

Our Products

Anti Cancer Medicine

Antidiabetic Medicine

Hormone Therapy Medicine

Anti HIV Medicine

Skin Cream

Monobenzone Cream USP 20% W-W

Pharma Vaccine Medicine

Anti Bacterial Medicine

Anti Malarial Medicine

Anti Viral Medicine

Hepatitis C Medicine

Osteoporosis Medicine

Antiarrhythmic Medicine

Mexiletine Hydrochloride Capsules IP

Erectile Dysfunction Medicine

SildenafilCitrate Tablets IP

Weight Management Medicine

Rheumatology Medicine

Skin Lightening Cream

Hydroquinone Plus Tretinoin Plus Mometasone Furoate Cream

Albumin Medicine

Hepatitis B Medicine

Entavir 1 mg Tablets

Neurology Medicine

Eye Drop

FDC Of Brinaolamide And Brimonidine Ophthalmic Suspension

Anti Fungal Medicine

Voriconazole Tablets IP 200 mg

Trastuzumab injection

Name: Trastuzumab injection
Brand: Parshva Agency
Price: 12000.0 INR
Availability: InStock

Price 12000.0 INR/ Bottle

Get a Price/Quote

MOQ : 100 Pieces

Trastuzumab injection Specification

Indication
HER2-positive breast cancer, metastatic gastric cancer

Salt Composition
Trastuzumab

Dosage Form
Injection

Enzyme Types
Monoclonal Antibody (not an enzyme)

Feature
Targeted therapy for HER2-positive cancer

Ingredients
Trastuzumab lyophilized powder, excipients

Application
Intravenous administration

Ph Level
6.0

Temperature Needed For Fermentation
Not applicable; manufacturing uses mammalian cell culture

Physical Color/Texture
White to pale yellow lyophilized powder

Fermentation Smell
Odorless

Storage Instructions
Store at 2C to 8C; do not freeze

Shelf Life
24 months

Contraindications
Hypersensitivity to Trastuzumab or excipients

Reconstitution
Reconstitute with sterile water for injection

Packaging Type
Single-use vial

Strength
440 mg/vial

Route of Synthesis
Recombinant DNA technology in mammalian cells

Therapeutic Class
Antineoplastic agent, Monoclonal antibody

Diluent Required
Sterile Water for Injection (SWFI)

Administration Route
Intravenous infusion only

Precautions
Monitor cardiac function before and during treatment

Preservation Conditions After Reconstitution
Use immediately or store refrigerated up to 24 hours

Trastuzumab injection Trade Information

Minimum Order Quantity
100 Pieces

FOB Port
MUMBAI

Payment Terms
Paypal, Telegraphic Transfer (T/T)

Supply Ability
100 Pieces Per Week

Delivery Time
1 Week

Sample Available
No

Sample Policy
If order is confirmed we will reimburse the sample cost

Packaging Details
1 VIAL

Main Export Market(s)
Asia, Middle East, Africa

Certifications
COA , GMP

About Trastuzumab injection

Herti 150mg Injection is used in the treatment of breast and stomach cancer. It works by killing the cancer cells by inhibiting HER2 (human epidermal growth factor receptor protein).

Targeted Therapy for HER2-Positive Cancers

Trastuzumab injection specifically targets the HER2 protein, providing effective treatment for HER2-positive breast and metastatic gastric cancer patients. Its action mechanism helps slow cancer progression, often improving patient outcomes.

Proper Reconstitution and Administration

The lyophilized powder must be reconstituted with sterile water for injection and administered exclusively as an intravenous infusion. Once prepared, the reconstituted solution should be used immediately or refrigerated for up to 24 hours to ensure efficacy and safety.

Handling and Storage Recommendations

Store the lyophilized vial at 2C to 8C and protect it from freezing. After reconstitution, any unused solution should be discarded after 24 hours. Always use under appropriate medical supervision to ensure patient safety.

FAQ's of Trastuzumab injection:

Q: How should Trastuzumab injection be prepared and administered?

A: Trastuzumab injection is supplied as a white to pale yellow lyophilized powder. It should be reconstituted with sterile water for injection, and the resulting solution administered intravenously as an infusion by a healthcare professional.

Q: What conditions does Trastuzumab treat?

A: Trastuzumab is indicated for the treatment of HER2-positive breast cancer and metastatic gastric cancer, targeting tumors that overexpress the HER2 protein.

Q: When should Trastuzumab injection be used after reconstitution?

A: It is best to use Trastuzumab immediately after reconstitution. If this is not possible, the solution can be stored under refrigeration (2C to 8C) and must be used within 24 hours.

Q: Where should Trastuzumab vials be stored before and after preparation?

A: Unreconstituted vials should be stored in a refrigerator at 2C to 8C. After reconstitution, the solution should be kept refrigerated and used within 24 hours; do not freeze at any stage.

Q: What monitoring is required during Trastuzumab treatment?

A: Cardiac function should be assessed before starting therapy and monitored periodically throughout treatment, as Trastuzumab can affect heart function in some patients.

Q: What are the benefits of using Trastuzumab for cancer treatment?

A: Trastuzumab is a targeted therapy that offers improved outcomes for patients with HER2-positive cancers, lowering the risk of disease progression compared to non-targeted treatments.